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Background: MicroRNAs (miRNAs) are small, non-coding RNAs that regulate gene expression and play a critical role
in development, homeostasis, and disease. Despite their demonstrated roles in age-associated pathologies, little is
known about the role of miRNAs in human aging and longevity.
Results: We employed massively parallel sequencing technology to identify miRNAs expressed in B-cells from
Ashkenazi Jewish centenarians, i.e., those living to a hundred and a human model of exceptional longevity, and
younger controls without a family history of longevity. With data from 26.7 million reads comprising 9.4 × 108 bp
from 3 centenarian and 3 control individuals, we discovered a total of 276 known miRNAs and 8 unknown miRNAs
ranging several orders of magnitude in expression levels, a typical characteristics of saturated miRNA-sequencing. A
total of 22 miRNAs were found to be significantly upregulated, with only 2 miRNAs downregulated, in centenarians
as compared to controls. Gene Ontology analysis of the predicted and validated targets of the 24 differentially
expressed miRNAs indicated enrichment of functional pathways involved in cell metabolism, cell cycle, cell
signaling, and cell differentiation. A cross sectional expression analysis of the differentially expressed miRNAs in
B-cells from Ashkenazi Jewish individuals between the 50th and 100th years of age indicated that expression levels
of miR-363* declined significantly with age. Centenarians, however, maintained the youthful expression level. This
result suggests that miR-363* may be a candidate longevity-associated miRNA.
Conclusion: Our comprehensive miRNA data provide a resource for further studies to identify genetic pathways
associated with aging and longevity in humans.
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MicroRNAs (miRNAs) are small non-coding RNAs that
regulate gene expression at the post-transcriptional level
[1]. Mature miRNAs, between 18–25 bp in length, are
transcribed as primary-miRNA (pri-miRNA) molecules
which contain a characteristic stem loop structure. This
stem loop targets pri-miRNA for processing by a number
of RNAses, namely Drosha and Dicer, which produce a
short RNA duplex [1]. From the duplex one or both* Correspondence: yousin.suh@einstein.yu.edu
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reproduction in any medium, provided the orstrands is incorporated into the RNA inducing silencing
complex (RISC), resulting in an active miRNA. Active
miRNAs target the 30 UTR of a mRNA based on sequence
homology [2]. The nucleotides in the 2–7 position of the
50 end of the mature miRNA comprise a “seed region”.
Once an mRNA is targeted by a miRNA it can be
degraded or its translation can be repressed through con-
served mechanisms leading to downregulation of gene
expression [1,3].
First described in C. elegans [3], many miRNAs have
been discovered across a wide range of species, including
humans. There is increasing evidence that miRNAs are
critical in a number of essential biological processes,
including cell differentiation [4], immune response [5],l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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miRNA sequences have been identified through cloning,
sequencing, or computational analysis (mirBase, release
16, 2010) [9-11].
The multitude of important roles played by miRNAs
suggests that they are a critical component of gene regu-
latory networks. However, the quantification of miRNAs
has been technically challenging due to their small size,
low copy number, interference from other small RNAs,
and contamination by degradation products of mRNAs
or other RNA species. Until recently only known and
computationally predicted miRNAs have been interro-
gated using hybridization-based array methods, which
suffer from cross-hybridization, and inability to discover
novel miRNAs due to limited array content. The increased
availability and affordability of massively parallel sequen-
cing now offer an opportunity to gain a high-resolution
view of miRNA expression, overcoming past experimental
limitations [12]. MiRNA-seq has been utilized to discover
novel and quantify expression levels of miRNAs in several
species, including humans [13,14].
Expression levels of genes are heritable in humans as
quantitative phenotypes, measurable in a variety of cell
types, including B-cells [15]. Recent studies, including
our own [16,17], have demonstrated that B cells reflect
functional characteristics of the donor and can be a useful
tool for studying genotype-driven molecular endpoints
such as gene expression, and expression quantitative trait
locus (eQTL) analysis [18,19]. B cells can act as surrogate
tissues whenever there is correlation between the expres-
sion levels of B cells and phenotypes of interest [20,21]
and a large number of eQTLs originally identified in B
cells can also be detected in multiple primary tissues
[22,23]. Thus B-cells have been increasingly utilized for
expression quantitative trait loci (eQTLs) studies [19,24]
and as a cell model to assess gene expression responses
[25]. While comprehensive mRNA expression data for
human B-cells, obtained by RNA-seq, are available for this
purpose [26], to date no such analysis was performed to
identify miRNAs expressed in B-cells. Here, we present
comprehensive miRNA transcriptome profiles of B-cells
from Ashkenazi Jewish centenarians and younger control
individuals by miRNA-seq, providing a resource that
could serve as a basis for establishing gene regulatory
interactions between miRNAs and their target mRNAs in
human B-cells.
Results
Discovery of miRNAs expressed in B-cells of centenarians
and controls
We generated small RNA libraries of B-cells from 3
Ashkenazi Jewish female centenarians (mean age 104)
and 3 Ashkenazi Jewish female younger controls (mean
age 63). Sequencing of these libraries by an Illuminatechnology platform yielded a total of 12.9 × 106 reads
from centenarians and 13.8 × 106 reads from controls
(Additional file 1: Table S1). After removal of low quality
reads and redundancy, we had a total of 1.1 × 106 and
1.0 × 106 unique reads for the centenarians and the
controls, respectively. Of the unique reads, those with a
read number greater than 10 in more than 50% (n = 3)
of the individuals sequenced (n = 6) were aligned to a
database of known miRNAs (http://www.mirbase.org/)
and other known small RNA species. MiRNAs with less
than 10 reads were not included due to the error rate of
Illumina sequencing and stochastic variation in gene
expression [12]. For all comparisons, the number of
reads for a given miRNA was normalized by division of
the total number of miRNA reads in that library, yielding a
normalized read count for each miRNA [12]. We identified
a total of 276 known miRNAs (Additional file 2: Table S2)
with a wide dynamic range of read counts ranging from 10
to over 1 million (Figure 1A). About 11% of these miRNAs
had a copy number greater than 10,000 and about 67%
a copy number less than 1,000. The identification of
276 miRNAs out of the 1048 reported human miRNAs
(mirBase, release 16, 2010) [9-11] is in the similar range
as observed by others for a particular cell type [14,27],
suggesting a saturation of miRNA-sequencing. The nor-
malized read count for each miRNA indicated that let-7f
was the most abundant miRNA detected in B-cells
(Figure 1B). The top 10 miRNAs by read count corre-
sponded to ~80% of all sequence reads in the B-cells
(Figure 1B). A complete list of miRNAs sequenced in each
library, normalized read counts, and fold differences
between centenarian and control cells is provided in
Additional file 2: Table S2.
To discover previously unknown novel miRNAs
among our short sequence RNAs that did not align to
the known miRNA database, we took advantage of the fact
that miRNAs are sequentially processed to their mature
form from stem-loop containing pre-miRNAs. Utilizing
the mirDeep program [28] we identified small RNAs that
correspond to processing of characteristic stem loop
containing pre-miRNAs. MirDeep uses a number of criteria
to select novel miRNAs [29], including a minimum free
energy of less than −25 kcal/mol, 25% sequence homology
with known miRNA precursors, sufficient GC content,
and no alignment to too many different genomic locations.
We discovered a total of 8 potentially novel miRNAs with
a characteristic stem loop structure that meet these criteria
(Table 1). None of the novel miRNAs were found to have
expression over 100,000 reads in any of our samples. All
putative miRNA precursors, with the exception of sRNA8,
had a lowest free energy and best folding structure resem-
bling known miRNA (Table 1). All of the putative miRNAs
and their genomic locations have been submitted to
mirBase.
Figure 1 Known miRNAs discovered in B-cells from centenarians and controls. (A) Distribution of the miRNAs expressed in B-cells according
to their sequence counts in centenarians and controls. On the vertical axis is a bin for miRNAs with sequence read counts within the given range.
In the horizontal axis is the numbers of miRNAs found for each of the magnitudes of expression. (B) Top 10 known miRNAs expressed in B-cells
from centenarians and controls, which constitute nearly 80% of all miRNAs expressed in the B-cells.
Gombar et al. BMC Genomics 2012, 13:353 Page 3 of 12
http://www.biomedcentral.com/1471-2164/13/353IsomiRs and variability of miRNA processing
Mature miRNAs are not always produced with the same
sequence even when originating from the same precursor
miRNA. Such mature variants have been termed “isomiRs”
[13]. A tissue-specific expression pattern of isomiRs during
development has been demonstrated in Drosophila,
suggesting a specific role of isomiRs in gene regulatory
networks [31]. A failure to identify all isomiRs can alter
sequence counts and lead to incorrect conclusions of
miRNA abundance [13]. Most of the variation in isomiRs
can be described by the variability in Dicer 1 and Drosha
processing of the miRNAs [32]. We compared thecomposition of isomiRs between B-cells originating from
centenarians vs. controls and identified a total of 694
variants from 261 miRNAs. Similar isomiR patterns were
identified in centenarian and control cells, suggesting that
global miRNA biogenesis is not significantly different
between centenarians and controls. A subset of identified
isomiRs and their compositions within the groups is listed
in Table 2. We found variants within our most abundant
miRNAs (e.g., hsa-let-7a and hsa-miR-21) and within our
differentially expressed miRNAs (e.g., hsa-miR148a and
hsa-miR-193b). There is evidence that the most abundant
isomiR in a sample is not always the same as the reference
Table 1 Novel miRNAs discovered in B-cells, their chromosome location, mature sequence, and putative
folding structure
Temporary name Genomic location Mature sequence Fold
sRNA1 chr11:95714237–95714346 || chr11:41380469-
41380478
ATCCCACCACTGCCACCA
sRNA2 chr11:46193225-46193334 TATCCCGGACGAGCCCCCA
sRNA3 chr1:218470812-218470921 CATGTGGGCTAGTTTCAGACAGGT
sRNA4 chr15:81221792–81221896 || chr15:545116- 545175 AAGGTAGATAGAACAGGTCTTG
sRNA5 chr17:76874327-76874436 ACCTTGGCTCTAGACTGCTTACT
sRNA6 chr17:24191370-24191479 GCTCTGACTTTATTGCACTACT
sRNA7 chr9:78376641-78376750 CGCTAAACCATTCGTAGACGACCTGCTTC
sRNA8 chr11:121147952–121148061 || chr11:13287835-
13287776
GGCTGGTCCGAAGGTAGTGAGT
Base-pair probabilities:
Novel miRNA were predicted using the mirDeep package. The pre-miRNA sequence of sRNA1 and sRNA5 were present in two genomic locations where miRNA
have not been previously predicted. The fold column was generated from mFold [30].
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variant of hsa-miR-21 not reported in mirBase was the
dominant isomiR. A complete list of sequenced isomiRs
from each individual miRNA discovered in B-cells is avail-
able in Additional file 3: Table S3.
MiRNAs differentially expressed between centenarians
and controls
To identify differentially expressed miRNAs, we performed
a Fisher’s exact test and adjusted for multiple testing with
Bonferroni correction [33-35]. We identified a total of 24
differentially expressed known miRNAs with a fold change
> 2.0 and Bonferroni corrected p-value < 0.05 (Table 3).Of the 24 differentially expressed miRNAs, 22 were
upregulated and only two downregulated in centenarians
as compared to controls (Figure 2). Normalized read
counts for the differentially expressed miRNAs ranged
from the 20s to over 100,000. A complete list of miRNAs
sequenced in each library, normalized read counts, and
fold changes between centenarians and controls is pro-
vided in Additional file 2: Table S2.
Cross platform comparison of differential miRNA
expression
Until recently, differentially expressed miRNAs were dis-
covered using miRNA microarray technology, which is
Table 2 Representative IsomiRs detected in B-cells
miRNA Sequence % Control % Centenarian
hsa-miR-21 TAGCTTATCAGACTGATGTTGAC 53.8% 52.0%
TAGCTTATCAGACTGATGTTGA 43.3% 44.9%
TAGCTTATCAGACTGATGTTGAA 2.7% 2.8%
TAGCTTATCAGACTGATGTTGAT 0.2% 0.3%
hsa-miR-193b AACTGGCCCTCAAAGTCCCGCT 84.8% 88.6%
AACTGGCCCTCAAAGTCCCGCTT 8.7% 5.9%
AACTGGCCCTCAAAGTCCCGCTA 6.2% 5.2%
AACTGGCCCTCAAAGTCCCGCTG 0.3% 0.3%
hsa-let-7a TGAGGTAGTAGGTTGTATAGTT 86.8% 86.9%
TGAGGTAGTAGGTTGTATAGTTA 9.3% 9.2%
TGAGGTAGTAGGTTGTATAGTTT 3.6% 3.5%
TGAGGTAGTAGGTTGTATAGTTG 0.4% 0.3%
hsa-miR-148a TCAGTGCACTACAGAACTTTGT 94.3% 94.3%
TCAGTGCACTACAGAACTTTGTC 3.9% 3.6%
TCAGTGCACTACAGAACTTTGTT 1.3% 1.4%
TCAGTGCACTACAGAACTTTGTA 0.5% 0.7%
Some of the top isomiRs are shown with the percent contribution of each isomiR to the total read count within each group. Reference sequence is denoted in
bold and isomer variation from the reference is noted with bold and underscore.
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detecting low abundance miRNAs and a limited dynamic
range, essentially constraining the detection of subtle
fold changes. These limitations call for an additional
technical validation step, for example, quantitative real
time PCR (qRT-PCR), which has been considered the
gold-standard of differential analysis of gene expression.
We conducted qRT-PCR analysis to validate the differ-
ential expression of 7 miRNAs out of the 24 miRNAs
found to be significantly different in B-cells from cente-
narians as compared to controls by Illumina sequencing
analysis. Five miRNAs (hsa-miR-363*, hsa-miR-1974,
hsa-miR-223*, hsa-miR-148a, hsa-miR-148a*) produced
expression patterns consistent with the Illumina sequen-
cing data (Figure 3). However, the qRT-PCR data clearly
underestimated the fold changes in gene expression
when compared with the Illumina sequencing analysis.
In addition, qRT-PCR failed to detect the expression of
hsa-miR-122 and hsa-miR-502-3p. These results indicate
that differential analysis of miRNAs by deep sequencing
should be the gold standard for quantification of miRNA
expression, especially since there is evidence for both 50
and 30 editing of mature miRNAs, which reduces the ef-
ficiency of miRNA detection by hybridization-based
method such as qRT-PCR [36].
Targets of differentially expressed miRNAs
Among the 24 differentially expressed miRNAs, several
have been previously characterized with known validated
targets (Additional file 4: Table S4), including hsa-miR-148 and hsa-miR-122 [5,37,38]. Target sites of the 24 differ-
entially expressed miRNAs were predicted using available
computational approaches, in particular TargetScan (http:
//www.targetscan.org) [39,40], miRanda (http://www.
microrna.org/microrna/home.do) [41], and PicTar (http://
pictar.mdc-berlin.de/) [42]. These software packages work
by finding an absolute base pair homology of the miRNA
seed region (bases 2–8 on the 50 end of the miRNA) to the
30 UTR of all mRNAs. In addition, they take into consider-
ation evolutionary conservation of 30 UTR bases as well as
RNA accessibility to the RISC complex. Due to the large
number of predicted targets we only considered target
genes with 2 predicted sites, an accessible 30UTR and
consensus amongst all prediction algorithms [27,43]. Based
on this approach we identified predicted target genes
for 10 out of the 24 differentially expressed miRNAs
(Additional file 4: Table S4). To explore the potential
pathways regulated by these miRNAs, we conducted
Gene Ontology analysis utilizing the “GoStat” analysis
tool (http://gostat.wehi.edu.au/). We took the total list
of predicted and validated targets of the differentially
expressed miRNAs and determined if any Gene Ontology
categories were over-represented within our list [44].
We found enrichment of functional pathways impli-
cated in the aging process, including cell metabolism,
cell cycle, cell signaling, and cell differentiation (Table 4)
among other significant GO categories (Additional file 5:
Table S5). In addition, we compared our putative target
list to the GenAge database which contains a collection of
genes implicated in aging [45] using a standard gene set
Table 3 Differentially expressed miRNAs in B-cells from centenarians vs. controls
miRNA Up regulated in Control counts
(standard error)
Centenarian counts
(standard error)
P values Bonferonni adjusted p values Fold change
hsa-miR-122 Centenarian 19 (6.26) 102 (6.39) 1.06E-16 2.44E-14 5.83
hsa-miR-363* Centenarian 184 (23.30) 837 (81.32) 3.6E-112 8.2E-110 4.94
hsa-miR-345 Centenarian 59 (10.65) 227 (32.69) 9.84E-28 2.27E-25 4.18
hsa-miR-20b Centenarian 306 (25.72) 1108 (240.38) 7.7E-122 1.8E-119 3.93
hsa-miR-454 Centenarian 39 (6.55) 126 (34.59) 1.02E-13 2.36E-11 3.51
hsa-miR-1974 Centenarian 4515 (660.27) 14179 (668.31) 0 0 3.41
hsa-miR-223* Centenarian 580 (39.17) 1800 (204.29) 2.2E-167 5.1E-165 3.37
hsa-miR-99b Centenarian 97 (15.32) 276 (83.78) 2.15E-24 4.96E-22 3.09
hsa-miR-181a* Centenarian 627 (24.30) 1641 (307.63) 4.5E-123 1E-120 2.84
hsa-miR-363 Centenarian 4732 (260.52) 11971 (2286.46) 0 0 2.75
hsa-miR-21* Centenarian 2529 (286.89) 6313 (1153.62) 0 0 2.71
hsa-miR-92b* Centenarian 99 (11.67) 245 (42.00) 2.45E-18 5.66E-16 2.69
hsa-miR-20b* Centenarian 319 (77.91) 708 (84.88) 5.78E-42 1.33E-39 2.41
hsa-miR-148a Centenarian 11599 (1225.92) 25583 (655.62) 0 0 2.40
hsa-miR-1975 Centenarian 1654 (86.54) 3529 (335.65) 2.1E-188 4.9E-186 2.32
hsa-miR-502-3p Centenarian 191 (13.48) 387 (14.66) 4.03E-20 9.31E-18 2.20
hsa-miR-181c Centenarian 153 (6.46) 310 (63.42) 1.8E-16 4.15E-14 2.20
hsa-miR-1259 Centenarian 106 (25.78) 210 (29.26) 4.01E-11 9.27E-09 2.15
hsa-miR-148a* Centenarian 339 (46.74) 656 (14.26) 3.38E-30 7.82E-28 2.10
hsa-miR-192 Centenarian 7126 (1026.34) 13754 (2446.01) 0 0 2.10
hsa-miR-361-5p Centenarian 307 (20.35) 587 (89.41) 1.65E-26 3.81E-24 2.08
hsa-miR-9 Centenarian 341 (26.37) 629 (37.72) 3.8E-26 8.78E-24 2.00
hsa-miR-151-3p Control 4515 (1288.82) 1352 (223.77) 0 0 3.07
hsa-miR-151-5p Control 257 (72.35) 80 (13.37) 7.22E-20 1.67E-17 2.96
All miRNA determined to be differentially expressed with a Bonferroni adjusted p-value < 0.05 and fold change > 2.0.
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a significant over-representation of these genes (Table 4).
Cross-sectional analysis of miRNA expression in different
age groups
Since 22 miRNAs out of 24 differentially expressed miR-
NAs were discovered to be upregulated in centenarians
(mean age: 103) as compared to controls (mean age: 63),
we set out to determine the mode of differential expres-
sion over a range of age groups. If upregulation is simply
age-related, expression will increase with age (Figure 4A).
In contrast, if the upregulation is longevity-related, patterns
of youthful expression will be preserved in centenarians
while its expression levels in control individuals decline
with age (Figure 4B). Among the differentially expressed
miRNAs, we chose hsa-miR-363* for a further validation
study because its upregulation in centenarians was detect-
able by qRT-PCR analysis with > 2 fold change (Figure 3).
We performed a cross-sectional study to measure miRNA
expression levels in B-cells established from 4 age groups of
Ashkenazi Jewish individuals; 50–60 (n = 5), 70–80 (n = 5),80–90 (n = 5), >100 years (n = 12). We found that the ex-
pression levels of hsa-miR-363* significantly declined with
age in control individuals (p < 0.05), while centenarians main-
tained comparable “high” expression levels of the youngest
age group (Figure 4C). The expression differences between
centenarians and younger elderly controls were significant
(p = 0.05 for 70–80 vs. > 100; p = 0.003 for 80–90 vs. > 100)
(Figure 4C), suggesting that hsa-miR-363* is a candidate
longevity-associated miRNA.
Discussion
We employed a massively parallel sequencing technol-
ogy to identify miRNAs expressed in B-cells established
from Ashkenazi Jewish Centenarians and younger eld-
erly controls without a family history of longevity. In this
study, which represents the first comprehensive studies
to analyze miRNAs in human B-cells, we obtained 26.7
million reads comprising 9.4 × 108 bp from 3 centenarian
and 3 control individuals. We found a total of 284 miR-
NAs expressed in human B-cells, eight of which were
previously unknown, putative novel miRNAs.
Differentially Expressed miRNA Species
Figure 2 Relative abundance and fold changes of miRNAs differentially expressed between centenarians and controls. Each sphere
along the X-axis represents a single miRNA that was found differentially expressed between centenarians and controls. The diameter of a sphere
represents the relative abundance of the miRNA read count. The Y-axis denotes the fold changes between the two groups. Positive values
denote up-regulation, and negative values denote down-regulation, of the miRNAs in centenarians as compared to controls.
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ance with increasing evidence for the role of miRNA ex-
pression in defining cellular phenotypes. Prior to the
advent of increasingly cost-effective, small RNA sequen-
cing, microarrays were the prevailing methods for
miRNA expression analysis. However, apart from noise
due to cross-hybridization to probes with similar short-Figure 3 Cross platform comparison of miRNA differential expression
differential expression of miRNAs detected by miRNA-seq. Standard error osequences, array technologies are limited in several key
ways. First, microarrays are limited to the probe sets,
eliminating the possibility to discover novel miRNAs.
Second, arrays are only able to identify the relative abun-
dance of miRNAs but not their absolute numbers [12].
Sequencing allows accurate detection of expression
levels over a wide dynamic range, including low copy. Quantitative RT-PCR with TaqMan probes was used to validate
f the mean for qPCR values are shown.
Table 4 Representative GO categories enriched in targets
of differentially expressed miRNAs
GO TERM GO ID p-Value (Bonferonni Adjusted)
cell differentiation GO:0030154 1.52 × 10-9
cellular metabolic
process
GO:0044237 3.82 × 10-6
cell-cell signaling GO:0007267 1.05 × 10-5
cell proliferation GO:0008283 6.66 × 10-5
cell cycle GO:0007049 8.02 × 10-4
GenAge Database 4.5 × 10-2
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and control groups. Finally, array-based methods cannot
differentiate isomiRs (mature miRNAs originated from
the same precursor but differing in one or more bases)
resulting from the high variability in miRNA processing
[13,31]. Using miRNA-seq of human B-cells, we were
able to identify novel miRNAs and isomiRs, and
detected expression of low-copy miRNAs and subtle fold
changes between centenarians and controls, which could
not be measured using TaqMan qPCR.
Genome-wide transcriptional profiles of miRNAs in C.
elegans [47] and human blood cells [48] showed that the
majority of miRNAs decreased in expression with age.
Likewise, cellular senescence was accompanied by signifi-
cant down-regulation in miRNA expression [49]. Our
results suggest that centenarians may be more resistant
to such age-related down-regulation of miRNAs because
the overwhelming majority of significant miRNAs are
increased in centenarians as compared to controls in B-
cells: we found 22 miRNAs significantly upregulated, with
only 2 downregulated, in centenarians as compared
to younger controls. Strikingly, expression levels of 5
miRNAs shown to be increased in centenarians (hsa-
miR-148a, hsa-miR-345, hsa-miR-361-5p, hsa-miR-192,
hsa-miR-454) have been demonstrated to be down-
regulated during cellular senescence (Table 5). Among
these, hsa-miR-148a was also found to be down-regulatedFigure 4 Cross-sectional expression of select miRNA in different age g
age 63) for differential analysis with centenarians (mean age 104). A) If diffe
age. B) If the differential expression is longevity-related, patterns of youthfu
levels in control individuals decline with age. C) A cross-sectional expressio
preservation mode: its expression levels significantly decline with age in co
levels of the youngest age group (50–60). The significance of expression di
individuals while centenarians had 12 individuals.with age in peripheral blood mononuclear cells (PBMCs)
[48]. Together, these results suggest that miRNAs asso-
ciated with longevity can be detected by cross-sectional
expression analysis as utilized in this work.
By conducting a cross-sectional analysis of miRNA
expression in different age groups, we found that expres-
sion of hsa-miR-363* significantly declined with age in
control individuals, whereas centenarians maintain com-
parably high expression levels, similar to the observed in
the middle age group. The results suggest that hsa-miR-
363* is a candidate longevity-associated miRNA. Previ-
ously miRNA* sequences were thought to be degraded.
However a growing body of work challenges the dogma
that miRNA* is simply a non-functional byproduct of
miRNA biogenesis, suggesting instead that miRNA*
plays a significant role in cellular function and human
disease [51]. Furthermore, they are implicated in the
aging of C. elegans [52]. The predicted targets of hsa-
miR-363* include PTEN, BCL2, AKT1, and IGFBP5
among genes listed in the GenAge database [45]. To our
knowledge this is the first cross-sectional analysis of
miRNA in a human longevity cohort, identifying a
potential longevity-associated miRNA.
Targets for our differentially expressed miRNAs were
obtained through the literature and by bioinformatics
means (Additional file 4: Table S4). The predicted and
validated targets of the 24 differentially expressed miR-
NAs are enriched in biological pathways implicated in
the aging process, including cell differentiation, cell
cycle, cell signaling, and cell metabolism (Table 4), as
well as the GenAge database [45]. Of particular interest
were the genes involved in cognitive aging (ADAMTS5,
APPL1, IGF2, LRP1b), aging-related signaling/transcrip-
tion (E2F2, FGF7, MLL, MYB , KLF3, PTEN, RICTOR,
SMAD2, SOCS5, TCF4), cell cycle/senescence/apoptosis
(BCL2L11, CBL , CDC2L6, E2F2, EEF2K), and overlap
with the GenAge database of known aging related genes
(SHC1, E2F1, STAT3, IGF1, IRS2, PTEN, RPA1, BCL2,
SP1, HBP1, MXD1). We searched for potential targetroups. The dotted line shows the age of the discovery group (mean
rential expression is simply age-related, expression will increase with
l expression will be preserved in centenarians while its expression
n analysis of hsa-miR-363* by quantitative RT-PCR showed the youthful
ntrol individuals (p < 0.05), while centenarians maintain the expression
fferences was assessed by student’s t-test. Each age group had 5
Table 5 Relevance of miRNAs differentially expressed in centenarians to senescence and aging
miRNA Up regulated in
centenarians
Down regulated in
centenarians
Up regulated in
senescence*
Down regulated in
senescence*
Down regulated in
aged PBMC**
hsa-miR-148a • • •
hsa-miR-345 • •
hsa-miR-361-5p • •
hsa-miR-192 • •
hsa-miR-454 • •
hsa-miR-122 • •
hsa-miR-502-3p • •
hsa-miR-151-5p • •
* Determined as differentially expressed in [50].
**Determined as differentially expressed in [48].
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found to be differentially expressed in our study because
it has been shown that miRNAs can act in an additive
manner and the co-targeting by multiple miRNAs would
greatly reduce mRNA expression even if the miRNAs
were in low copy number [53]. We found that RICTOR
(rapamycin-insenstive companion of mTOR) was pre-
dicted to bind at least two miRNAs upregulated in
centenarians as compared to controls. The 30 UTR of
RICTOR and the binding sites for miR-148a and miR-
155 (fold change > 1.5) are shown in Figure 5. RICTOR
is part of the TOR family of genes which are integral to
growth and proliferation, and down-regulation of this
pathway is shown to extend lifespan [54].
Longevity is known to have a genetic component in
humans. While the heritability of average life expectancy
has been estimated to be only ~25% [55,56], studies of
centenarians indicate much stronger heritability at old
age. For example, siblings of centenarians have a 4 times
greater probability of surviving to age 90 than siblings of
people with average life span [57]. Achieving a lifespan
of 100 years is 17 and 8 times more likely for male or
female siblings of centenarians, respectively, compared
to their birth cohort [58]. These findings firmly estab-
lished the utility of human centenarians as a model
system to unravel the genetics of longevity. For this
study, we used our unique cohort of centenarians and
elderly controls without family history of exceptional
longevity, all of genetically homogeneous Ashkenazi
Jewish descent. This cohort has been used to success-
fully discover longevity associated genotypes and pheno-
types in the past [16,59].Figure 5 30 UTR of Rictor showing multiple miRNA target locations.Recently, miRNAs have emerged as critical regulators
of gene expression and a link between multiple miRNAs
and longevity [8,60] and aging [47] has been demon-
strated in C. elegans, implicating their role in regulation
of lifespan and in the aging process. Since a significant
number of miRNAs are evolutionarily conserved [61,62],
it is conceivable that miRNAs play a role in human lon-
gevity as well. Our finding that most of the differentially
expressed miRNAs were upregulated in centenarians
could point towards increased resilience of centenarians
against an age-related decline in gene regulatory control.
By conducting a cross-sectional expression analysis, we
found a candidate longevity-associated miRNA, hsa-
miR-363* (Figure 4). Hsa-miR-363* shows reduced ex-
pression in control individuals with advancing age while
maintaining relatively high expression levels in centenar-
ians. Maintenance of youthful expression patterns may
be beneficial and longevity-associated miRNAs may con-
fer robustness to gene expression networks, protecting
them against age-related deterioration.
In the field of human genetics, most of the surveys
of gene expression have been conducted in B-cells be-
cause they are readily available and can be used mul-
tiple times under controlled experimental conditions
[15,63]. B cells act as surrogate tissues whenever there
is a correlation between expression levels in these cells
and phenotypes of interest [20,21]. However, caution
needs to be taken in interpreting the results, especially
with negative data, as truly tissue-specific genes will
not be detected in B-cells. The lack of a correlation can
never be used to infer that the miRNA/gene is not
involved in human longevity, and only positive results
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based science.Conclusions
Massively parallel sequencing technology allowed us to
accurately detect miRNAs expressed in B-cells. Consid-
ering the increasing use of B-cells for genetic and func-
tional studies [16,64] our data provides a resource for
designing gene expression studies and to study gene
regulatory networks mediated by miRNAs. Furthermore,
our results from B-cells established from a human longevity
cohort may generate an opportunity to explore the possible
role of miRNAs in human aging and longevity and to
identify genes and pathways that are targets for age-
related alteration.Methods
Population and sample collection
All individuals are enrolled in the Longevity Genes Project,
and were recruited as described previously [65]. Informed
written consent was obtained in accordance with the
policy of the Committee on Clinical Investigations of
the Albert Einstein College of Medicine. All blood samples
were processed at the General Clinical Research Center
at the Albert Einstein College of Medicine in order to
produce EBV transformed immortalized B-cells as a
source of RNA. Total RNA was extracted from immor-
talized B-cell lines established from centenarians and
controls using TRIZOL reagent as recommended by
the manufacturer (Invitrogen).Ethics
Experimental research reported in this manuscript has
been performed with the approval of the Committee on
Clinical Investigations of the Albert Einstein College of
Medicine. Research carried out in this manuscript is in
compliance with the Helsinki Declaration (http://www.
wma.net/e/policy/b3.htm).MiRNA-sequencing
MiRNA-seq was performed as recommended by the
manufacturer (Illumina small RNA prep kit v 1.5). 10 μg
of total RNA from each sample was resolved on a 15%
TBE-Urea polyacrylamide gel followed by the excision of
gels corresponding to the 17–35 nucleotides. Small
RNAs were isolated from the gel in 300 μl of 0.3 M
NaCl for 4 hours at room temperature. The small RNAs
were ligated with a biotinylated RNA-DNA 30-adaptor,
gel-purified, and ligated with a 50-adaptor. Products with
both adaptors were gel-purified, reverse-transcribed, and
PCR amplified for 14 cycles. Sequencing was performed
on an Illumina GA1 analyzer.Data analysis
The sequencing data was provided from the GA1
sequencer in a standard fastq format [66]. The fastq files
were trimmed of adapter sequences and of low quality
reads (reads which had more than 3 base-calls below
sufficient quality value), through a c++ program. These
sequences were then collapsed to remove redundancy
using the Galaxy Genome Browser tool fastx [67]. At
this point sequences from each of the samples was
aligned to the known human miRNA/small RNA data-
base or put into the mirDeep pipeline for the discovery
of novel miRNAs [28]. To normalize the samples we
determined how frequently the miRNA was annotated
per the number of reads reported from the sequencer
[12]. The basis of this idea is that for a given number of
small sequences isolated from a cell there should be on
average the same number of total miRNAs from the
sample. Read counts from different libraries were nor-
malized to the total reads in each sample [12].Statistical analysis
After normalization any reads observed in fewer than 3
samples or with a copy number less than 10 were not
considered for analysis; this correction removed ex-
tremely low abundance miRNAs. To identify differen-
tially expressed miRNAs, the data was analyzed through
Fisher’s exact test using a Bonferonni correction [33-35]
for multiple hypothesis testing. Those miRNAs meeting
a corrected cutoff with a p-value below 0.05 and with a
fold change greater than 2.0 were considered differen-
tially expressed.Quantitative RT- PCR analysis
Total RNA was isolated from B-cells using RNA isola-
tion kit (Qiagen, Valencia, CA) and then converted to
complementary DNA using TaqMan Reverse Transcrip-
tion kit (Applied Biosystems, Foster City, CA) with micro-
RNA specific RT primer (Applied Biosystems). A TaqMan®
microRNA assay was performed using AB StepOneTM
real-time PCR system to quantify relative miRNAs expres-
sion in these samples. The 20 μl total volume final reaction
mixture consisted of 1 μl of TaqMan microRNA specific
primer, 10 μl of 2x Universal Master Mix with no
AmpErase® UNG (Applied Biosystems) and 1.3 μl of
complementary DNA. PCR was performed using the
following conditions: 50°C for 2 min, 95°C for 10 min,
40 cycles of 95°C for 15 sec, and 60°C for 1 min. All
reactions were run in duplicate to reduce confounding
variance. U6 snRNA (Applied Biosystems) was used as
an internal control. Means from different conditions
were compared using the Student’s t-test. A significance
threshold of P < 0.05 was used.
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